Ogawa M, Ariyoshi Y
Aichi Cancer Center, Nagoya, Japan.
Hematol Oncol Clin North Am. 1994 Apr;8(2):277-87.
A total of 16 drugs developed in Japan are currently under Phase I or II trials. This article reviews results of some studies of these drugs. Studies included in the article are of SM-5887, MX-2, DWA2114R, and CPT-11.
目前有16种在日本研发的药物正处于一期或二期试验阶段。本文回顾了其中一些药物的研究结果。文中纳入的研究药物有SM-5887、MX-2、DWA2114R和CPT-11。